Ligamentoplasty of Ligamentum Tere Developmental Dysplasia of the Hip

October 29, 2022 updated by: Ahmed Obeid Abd Allah, Al-Azhar University

The Role of Ligamentoplasty of Ligamentum Tere in the Management of Developmental Dysplasia of the Hip

The hip is formed by the acetabulum, the proximal femur and soft tissues joining them (capsule, teres ligament, transverse ligament and pulvinar). The acetabulum is a complex structure in the growing child. It is formed by the joined pubis, This junction is called tri radiate cartilage, which is responsible for acetabular growth. The external surface of the acetabulum is covered by a horse shoe-shaped articular cartilage. The transverse ligament joins both extremes of the articular cartilage inferiorly.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: ahmed khashaba
  • Phone Number: 01023233949

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 months to 3 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The patients will be examined for:

Length of both lower limbs in relation to each other. Length of both lower limbs according to patient age. Presence of hump related to the outer surface of the hip Presence of pain, abnormal gait, Trendlenburg test Radiographic evaluation (antero posterior and frog pelvis views)

An addition to the steps of the open reduction, the following were done:

Identification of ligamentum teres and ligamentoplasty

Description

Inclusion Criteria:

  • Patient with Developmental dysplasia of the hip (DDH) with :

    • Age: from 9 months -3 years old.
    • Virgin DDH.
    • Failed closed reduction in the management of DDH.
    • Failed open reduction through medial approach in the management of DDH.

Exclusion Criteria:

  • • Paralytic hip dislocation .

    • Post septic hip dislocation.
    • Traumatic hip dislocation .
    • Age : below 9 months or above 5 years.
    • Refusal to participate in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ligamentoplasty of ligamentum teres

The patients will be examined for:

  1. Length of both lower limbs in relation to each other.
  2. Length of both lower limbs according to patient age.
  3. Presence of hump related to the outer surface of the hip
  4. Presence of pain, abnormal gait, Trendlenburg test.

An addition to the steps of the open reduction, the following were done:

  1. Identification of ligamentum teres
  2. Ligamentoplasty of ligamentum teres
Procedure: ligamentoplasty of ligamentum teres

An addition to the steps of the open reduction, the following were done:

  1. Identification of ligamentum teres
  2. Ligamentoplasty of ligamentum teres

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
modified Harris Hip Score
Time Frame: 6 months
score for function of the hip
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Al-Azhar University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 29, 2022

Primary Completion (Anticipated)

November 29, 2023

Study Completion (Anticipated)

November 29, 2023

Study Registration Dates

First Submitted

October 29, 2022

First Submitted That Met QC Criteria

October 29, 2022

First Posted (Actual)

November 3, 2022

Study Record Updates

Last Update Posted (Actual)

November 3, 2022

Last Update Submitted That Met QC Criteria

October 29, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • LPLT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthopedic Disorder

Clinical Trials on ligamentoplasty of ligamentum teres

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe